Morgan Stanley’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.1K | Buy |
|
|||||
|
2025
Q1 | $105K | Sell |
|
|||||
|
2024
Q4 | $1.67M | Buy |
|
|||||
|
2024
Q3 | $759K | Buy |
|
|||||
|
2024
Q2 | $124K | Sell |
|
|||||
|
2024
Q1 | $370K | Sell |
|
|||||
|
2023
Q4 | $2.48M | Buy |
|
|||||
|
2023
Q3 | $879K | Sell |
|
|||||
|
2023
Q2 | $2.21M | Buy |
|
|||||
|
2023
Q1 | $1.1M | Sell |
|
|||||
|
2022
Q4 | $1.23M | Buy |
|
|||||
|
2022
Q3 | $765K | Sell |
|
|||||
|
2022
Q2 | $770K | Sell |
|
|||||
|
2022
Q1 | $4.24M | Buy |
|
|||||
|
2021
Q4 | $4.54M | Sell |
|
|||||
|
2021
Q3 | $4.74M | Buy |
|
|||||
|
2021
Q2 | $15M | Buy |
|
|||||
|
2021
Q1 | $7.28M | Buy |
|
|||||
|
2020
Q4 | $3.7M | Buy |
|
|||||
|
2020
Q3 | $2.76M | Sell |
|
|||||
|
2020
Q2 | $480K | Buy |
|
|||||
|
2020
Q1 | $348K | Sell |
|
|||||
|
2019
Q4 | $496K | Buy |
|
|||||
|
2019
Q3 | $473K | Sell |
|
|||||
|
2019
Q2 | $460K | Sell |
|
|||||
|
2019
Q1 | $1.87M | Buy |
|
|||||
|
2018
Q4 | $780K | Sell |
|
|||||
|
2018
Q3 | $1.33M | Buy |
|
|||||
|
2018
Q2 | $1.43M | Sell |
|
|||||
|
2018
Q1 | $1.46M | Buy |
|
|||||
|
2017
Q4 | $1.1M | Buy |
|
|||||
|
2017
Q3 | $802K | Buy |
|
|||||
|
2017
Q2 | $311K | Sell |
|
|||||
|
2017
Q1 | $506K | Sell |
|
|||||
|
2016
Q4 | $919K | Buy |
|
|||||
|
2016
Q3 | $784K | Buy |
|
|||||
|
2016
Q2 | $1.02M | Sell |
|
|||||
|
2016
Q1 | $1.22M | Buy |
|
|||||
|
2015
Q4 | $1.19M | Buy |
|
|||||
|
2015
Q3 | $307K | Buy |
|
|||||
|
2015
Q2 | $104K | Buy |
|